These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38716459)

  • 1. Impact of Respiratory Bacterial Findings on Patients with Chronic Pulmonary Aspergillosis.
    Cho HK; Moon SM; Kim HT; Shin B
    Int J Microbiol; 2024; 2024():1329884. PubMed ID: 38716459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics of patients with Aspergillus species isolation from respiratory samples: Comparison of chronic pulmonary aspergillosis and colonization.
    Ohara S; Tazawa Y; Tanai C; Tanaka Y; Noda H; Horiuchi H; Usui K
    Respir Investig; 2016 Mar; 54(2):92-7. PubMed ID: 26879478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics and prognosis of chronic pulmonary aspergillosis.
    Ohba H; Miwa S; Shirai M; Kanai M; Eifuku T; Suda T; Hayakawa H; Chida K
    Respir Med; 2012 May; 106(5):724-9. PubMed ID: 22349065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic Laboratory Features and Performance of an
    Zhu RS; Zhou LH; Cheng JH; Luo Y; Qiu WJ; Huang JT; Jiang YK; Zhao HZ; Wang X; Chen ZQ; Zhu LP
    Microbiol Spectr; 2023 Jun; 11(3):e0026423. PubMed ID: 37125929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of Microbiological and Clinical Characteristics of Bacterial Infection in Patients with Pulmonary Infection.
    Duan T
    Comput Intell Neurosci; 2022; 2022():5607358. PubMed ID: 35755768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1997)].
    Ikemoto H; Ito C; Yoshida T; Watanabe K; Mori T; Ohno I; Okada S; Igari J; Arakawa M; Igarashi K; Oguri T; Okada M; Ozaki K; Terai T; Aoki N; Inoue H; Nakadate T; Kitamura N; Sekine O; Suzuki Y; Ando M; Suga M; Sato K; Nakata K; Kusano N
    Jpn J Antibiot; 1999 May; 52(5):353-97. PubMed ID: 10480048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-level analysis of bacteria isolated from inpatients in respiratory departments in China.
    Tang X; Xiao M; Zhuo C; Xu Y; Zhong N
    J Thorac Dis; 2018 May; 10(5):2666-2675. PubMed ID: 29997928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the
    Li H; Rui Y; Zhou W; Liu L; He B; Shi Y; Su X
    Front Microbiol; 2019; 10():1438. PubMed ID: 31316486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1994)].
    Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kobayashi K; Satou K; Matsumiya H; Saito A; Terai T; Tanno Y; Nishioka K; Arakawa M; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Matsuda M; Tanimoto H; Nakata K; Nakamori Y; Kusano N
    Jpn J Antibiot; 1996 May; 49(5):419-55. PubMed ID: 8752860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Microbiological characteristics of patients with severe burns caused by blast and application of meta- genomics next-generation sequencing in the detection of pathogenic microorganisms].
    Luo RB; Huang M; Hu H; Zhang R; Han CM
    Zhonghua Shao Shang Za Zhi; 2021 Oct; 37(10):946-952. PubMed ID: 34689464
    [No Abstract]   [Full Text] [Related]  

  • 11. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2005)].
    Goto H; Takeda H; Kawai S; Watanabe S; Okazaki M; Shimada K; Nakano K; Yokouchi H; Mori T; Igari J; Oguri T; Yamamoto M; Kudo K; Kobayashi N; Tanaka T; Yoshimura K; Kawabata M; Nakamori Y; Sumitomo M; Inoue H; Nakadate T; Suwabe A; Ashino Y; Aoki N; Honma Y; Suzuki Y; Karasawa Y; Oka M; Kobashi Y; Kohno S; Hirakata Y; Kondou A; Matsuda J; Nakano M; Oikawa S
    Jpn J Antibiot; 2008 Aug; 61(4):209-40. PubMed ID: 19024644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic pulmonary aspergillosis in a tertiary care centre in Spain: A retrospective, observational study.
    Aguilar-Company J; Martín MT; Goterris-Bonet L; Martinez-Marti A; Sampol J; Roldán E; Almirante B; Ruiz-Camps I
    Mycoses; 2019 Sep; 62(9):765-772. PubMed ID: 31162731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential value of serum Aspergillus IgG antibody detection in the diagnosis of invasive and chronic pulmonary aspergillosis in non-agranulocytic patients.
    Yu Q; He J; Xing B; Li X; Qian H; Zhang H; Xu M; Peng H
    BMC Pulm Med; 2020 Apr; 20(1):89. PubMed ID: 32293386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The risk factors for developing of chronic pulmonary aspergillosis in nontuberculous mycobacteria patients and clinical characteristics and outcomes in chronic pulmonary aspergillosis patients coinfected with nontuberculous mycobacteria.
    Takeda K; Imamura Y; Takazono T; Yoshida M; Ide S; Hirano K; Tashiro M; Saijo T; Kosai K; Morinaga Y; Nakamura S; Kurihara S; Tsukamoto M; Miyazaki T; Tashiro T; Kohno S; Yanagihara K; Izumikawa K
    Med Mycol; 2016 Feb; 54(2):120-7. PubMed ID: 26531100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis of chronic pulmonary aspergillosis in patients with pulmonary non-tuberculous mycobacterial disease.
    Naito M; Kurahara Y; Yoshida S; Ikegami N; Kobayashi T; Minomo S; Tachibana K; Tsuyuguchi K; Hayashi S; Suzuki K
    Respir Investig; 2018 Jul; 56(4):326-331. PubMed ID: 29764749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of chronic pulmonary aspergillosis regarding time of tuberculosis diagnosis in Brazil.
    Volpe-Chaves CE; Venturini J; B Castilho S; S O Fonseca S; F Nunes T; T Cunha EA; M E Lima G; O Nunes M; P Vicentini A; V L Oliveira SM; Carvalho LR; Thompson L; P Mendes R; M M Paniago A
    Mycoses; 2022 Jul; 65(7):715-723. PubMed ID: 35524507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1999)].
    Shimada K; Nakano K; Ohno I; Okada S; Hayashi K; Yokouchi H; Arakawa M; Gejyo F; Igarashi K; Ikemoto H; Mori T; Okada M; Ozaki K; Igari J; Aoki N; Oguri T; Kitamura N; Terai T; Suzuki Y; Inoue H; Nakadate T; Karasawa Y; Ito C; Yoshida T; Nakata K; Nakatani T; Inagawa H; Ando M; Suga M; Sato K; Kudo K; Kobayashi N; Tosaka M; Hasegawa M; Kohno S; Tomono K; Miyazaki Y; Kobayashi H; Kawai S; Takayasu S; Hirakata Y; Matsuda J; Mochida C; Ito A; Sumitomo M; Nasu M; Nagai H; Matsushima T; Niki Y; Hiramatsu K; Nakano T
    Jpn J Antibiot; 2001 Jul; 54(7):331-64. PubMed ID: 11560054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2000)].
    Shimada K; Terai T; Igari J; Inoue H; Nakadate T; Oguri T; Suwabe A; Obata R; Ikemoto H; Ohno I; Okada S; Hayashi K; Mori T; Nakano K; Arakawa M; Gejyo F; Igarashi K; Yokouchi H; Okada M; Ito A; Sumitomo M; Aoki N; Matsushima T; Niki Y; Kitamura N; Suga M; Suzuki Y; Karasawa Y; Tosaka M; Nakata K; Nakatani T; Kohno S; Tomono K; Miyazaki Y; Inagawa H; Hirakata Y; Aoki S; Matsuda J; Kudo K; Kobayashi N; Kinoshita T; Konosaki H; Nasu M; Nagai H; Kobayashi H; Kawai S; Takayasu S; Hiramatsu K; Nakano T
    Jpn J Antibiot; 2002 Oct; 55(5):537-67. PubMed ID: 12532637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-
    Takeda K; Suzuki J; Watanabe A; Narumoto O; Kawashima M; Sasaki Y; Nagai H; Kamei K; Matsui H
    J Clin Microbiol; 2022 Feb; 60(2):e0201821. PubMed ID: 34878803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical manifestations, associated risk factors and treatment outcomes of Chronic Pulmonary Aspergillosis (CPA): Experiences from a tertiary care hospital in Lahore, Pakistan.
    Akram W; Ejaz MB; Mallhi TH; Syed Sulaiman SAB; Khan AH
    PLoS One; 2021; 16(11):e0259766. PubMed ID: 34767589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.